These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9760681)

  • 1. Discovery and development of somatostatin agonists.
    Marbach P; Bauer W; Bodmer D; Briner U; Bruns C; Kay A; Lancranjan I; Pless J; Raulf F; Robison R; Sharkey J; Soranno T; Stolz B; Vit P; Weckbecker G
    Pharm Biotechnol; 1998; 11():183-209. PubMed ID: 9760681
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatostatin and somatostatin analogues in human breast carcinoma.
    Prévost G; Israel L
    Recent Results Cancer Res; 1993; 129():63-70. PubMed ID: 8102489
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptor.
    Palii SS; Afzal A; Shaw LC; Pan H; Caballero S; Miller RC; Jurczyk S; Reubi JC; Tan Y; Hochhaus G; Edelhauser H; Geroski D; Shapiro G; Grant MB
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5094-102. PubMed ID: 18599562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on radiolabeled somatostatin analogues in rats and in patients.
    Breeman WA; Bakker WH; De Jong M; Hofland LJ; Kwekkeboom DJ; Kooij PP; Visser TJ; Krenning EP
    Q J Nucl Med; 1996 Sep; 40(3):209-20. PubMed ID: 8961800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New somatostatin analogues for radiotherapy of somatostatin receptor expressing tumours.
    Stolz B; Smith-Jones P; Albert R; Weckbecker G; Bruns C
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S224-6. PubMed ID: 10604136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
    Ferone D; van Hagen MP; Kwekkeboom DJ; van Koetsveld PM; Mooy DM; Lichtenauer-Kaligis E; Schönbrunn A; Colao A; Lamberts SW; Hofland LJ
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1719-26. PubMed ID: 10770220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
    Janson ET; Oberg K
    Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
    [No Abstract]   [Full Text] [Related]  

  • 8. [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
    Banzo J; Abós MD; Prats E; García F; Razola P
    Rev Esp Med Nucl; 2000 Jun; 19(3):225-41. PubMed ID: 11062088
    [No Abstract]   [Full Text] [Related]  

  • 9. Somatostatin analogs for diagnosis and treatment of cancer.
    Weckbecker G; Raulf F; Stolz B; Bruns C
    Pharmacol Ther; 1993 Nov; 60(2):245-64. PubMed ID: 7912834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures.
    Djordjijevic D; Zhang J; Priam M; Viollet C; Gourdji D; Kordon C; Epelbaum J
    Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment.
    Froidevaux S; Hintermann E; Török M; Mäcke HR; Beglinger C; Eberle AN
    Cancer Res; 1999 Aug; 59(15):3652-7. PubMed ID: 10446977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterisation of [90Y]-Bz-DTPA-oct: a yttrium-90-labelled octreotide analogue for radiotherapy of somatostatin receptor-positive tumours.
    Smith-Jones PM; Stolz B; Albert R; Ruser G; Briner U; Mäcke HR; Bruns C
    Nucl Med Biol; 1998 Apr; 25(3):181-8. PubMed ID: 9620621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy.
    Ben-Shlomo A; Schmid H; Wawrowsky K; Pichurin O; Hubina E; Chesnokova V; Liu NA; Culler M; Melmed S
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4342-50. PubMed ID: 19820006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs.
    Dörr U; Wurm K; Höring E; Guzman G; Räth U; Bihl H
    Horm Metab Res Suppl; 1993; 27():36-43. PubMed ID: 8330870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis.
    Imhof AK; Glück L; Gajda M; Lupp A; Bräuer R; Schaible HG; Schulz S
    Arthritis Rheum; 2011 Aug; 63(8):2352-62. PubMed ID: 21506098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.
    Kvols LK; Reubi JC; Horisberger U; Moertel CG; Rubin J; Charboneau JW
    Yale J Biol Med; 1992; 65(5):505-18; discussion 531-6. PubMed ID: 1364090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
    Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC
    J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma.
    Meyer P; Bohnen NI; Barkan AL; Shapiro B
    Nuklearmedizin; 1999; 38(2):66-7. PubMed ID: 10100234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.
    Ugur O; Kothari PJ; Finn RD; Zanzonico P; Ruan S; Guenther I; Maecke HR; Larson SM
    Nucl Med Biol; 2002 Feb; 29(2):147-57. PubMed ID: 11823119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptors: clinical implications for endocrinology and oncology.
    Lamberts SW; de Herder WW; van Koetsveld PM; Koper JW; van der Lely AJ; Visser-Wisselaar HA; Hofland LJ
    Ciba Found Symp; 1995; 190():222-36; discussion 236-9. PubMed ID: 7587649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.